Laboratory Investigation

Published by: Nature Publishing Group  

People

  1. Dogan
    Dogan
  2. Arcila
    Arcila
  3. Roshal
    Roshal
  4. Levine
    Levine
  5. Baik
    Baik
  6. Zelenetz
    Zelenetz
  7. Zhang
    Zhang
  8. Abdel-Wahab
    Abdel-Wahab
  9. Rampal
    Rampal
  10. Xiao
    Xiao

Groups

  1. Department of Medicine (45)
  2. Hematologic Malignancies, Division of (45)
  3. Center for Hematologic Malignancies (37)
  4. Department of Pathology and Laboratory Medicine (33)
  5. Adult Leukemia (19)
  6. GSK Faculty (19)
  7. Executive Committee, Center for Hematologic Malignancies (17)
  8. Human Oncology and Pathogenesis Program (15)
  9. Lymphoma (14)
  10. Tow Center for Developmental Oncology (TCDO) (12)
Search Within
  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (45)
Groups
  1. Department of Medicine (45)
  2. Hematologic Malignancies, Division of (45)
  3. Center for Hematologic Malignancies (37)
  4. Department of Pathology and Laboratory Medicine (33)
  5. Adult Leukemia (19)
  6. GSK Faculty (19)

More Groups

People
  1. Ahmet Dogan (18)
  2. Maria Arcila (13)
  3. Mikhail Roshal (10)
  4. Ross Levine (8)
  5. Andrew Zelenetz (6)
  6. Janine Pichardo (6)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2020 (6)
  5. 2019 (4)
  6. 2016 (8)

More Years

Publishers
  1. Nature Publishing Group (45)

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of NECTIN4 amplification and expression with response to enfortumab vedotin (EV) treatment in locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Yol, C.; Irawan, H.; Sternschuss, M.; Gupta, A.; Bent, E.; Basar, M.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Pathologic response and histologic features of cytoreductive nephrectomy (CN) following immunotherapy (IO) for patients with metastatic renal cell carcinoma (RCC)
    Meeting Abstract

    Wu, C. Y.; Reese, S.; Al-Ahmadie, H.; Fine, S.; Gopalan, A.; Sarungbam, J.; Sirintrapun, S. J.; Kotecha, R.; Voss, M.; Coleman, J.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Distinct genomic alterations in radiation-induced angiosarcoma compared to other radiation-associated sarcoma histologies: Rationale for individualized therapeutic targeting
    Meeting Abstract

    Dermawan, J.; Chi, P.; Tap, W.; Rosenbaum, E.; D'Angelo, S.; Alektiar, K.; Antonescu, C.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Applying lymphgen classification to a clinically validated 400-gene targeted next-generation sequencing (NGS) panel in diffuse large b-cell lymphoma (DLBCL)
    Meeting Abstract

    Zhu, M.; Drill, E.; Joffe, E.; Arcila, M.; Dogan, A.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • UV genomic signature classifies lung melanomas of unknown primary as metastases from occult cutaneous melanomas
    Meeting Abstract

    Yang, C.; Sanchez-Vega, F.; Shoushtari, A.; Ladanyi, M.; Travis, W.; Busam, K.; Rekhtman, N.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Frequent TET2 mutations in histiocytic neoplasms
    Meeting Abstract

    Liu, Y.; Petrova-Drus, K.; Durham, B.; Baik, J.; Sigler, A.; Rampal, R.; Abdel-Wahab, O.; Diamond, E.; Dogan, A.; Yabe, M.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Single-cell evaluation of myelodysplastic syndrome stem cells identifies determinants of hypomethylating agent response and a novel prognostic gene signature
    Meeting Abstract

    Javidiparsijani, S.; Dolgalev, I.; Vijay, P.; Gonzalez, M. D.; Devlin, S.; Klimek, V.; Chung, S.; Mason, C.; Park, C.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Erythroid/megakaryoblastic leukemia with TP53 and RUNX1 mutations frequently occurs in blast transformation of Philadelphia chromosome-negative myeloproliferative neoplasms: A single-institution experience with 56 cases
    Meeting Abstract

    Liu, Y.; Mata, D.; Baik, J.; Famulare, C.; Sigler, A.; Arcila, M.; Zhang, Y.; Dogan, A.; Tallman, M.; Levine, R.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis (CH) in angioimmunoblastic T-cell lymphoma (AITL) with divergent evolution to myeloid neoplasms (MNs)
    Meeting Abstract

    Lewis, N.; Petrova-Drus, K.; Epstein-Peterson, Z.; Huet, S.; Gao, Q.; Sigler, A.; Baik, J.; Kumar, A.; Horwitz, S.; Zhang, Y.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Frequent RUNX1 and TP53 mutations in secondary acute myeloid leukemia with mixed phenotype
    Meeting Abstract

    Galera, P.; Baik, J.; Famulare, C.; Sigler, A.; Zhang, Y.; Arcila, M.; Dogan, A.; Tallman, M.; Levine, R.; Glass, J.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save

    • Laboratory Investigation – authorized name for:

    Name ISSN / ISBN Publisher
    Laboratory Investigation 00236837 Nature Publishing Group
    Laboratory Investigation 0023-6837 Lippincott Williams & Wilkins
    Laboratory Investigation 0023-6837 Nature Publishing Group
    Laboratory Investigation 0023-6837 Nature Publishing Group
    Laboratory Investigation 0023-6837 Unknown
    Laboratory Investigation 00236837 Unknown
    Laboratory Investigation 0023-6837 Williams & Wilkins
    Laboratory Investigation 00236837 Uscap, Inc
    Laboratory Investigation 0023-6837 Elsevier Science, Inc.
    Laboratory Investigation 0023-6837 Elsevier Science, Inc.
    Laboratory Investigation 0023-6837 Nature Publishing Group
    Laboratory Investigation 0023-6837 Nature Publishing Group